Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-420-7 | CAS number: 53185-52-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Remarks:
- theoretical assessment
- Type of information:
- other: theoretical assessment based on all available information
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: expert statement
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- An evaluation of the toxicokinetics of 3-methoxy-N,N-dimethyl propanamide was conducted based on the results of the toxicological test package and the physico-chemical properties.
- GLP compliance:
- no
- Species:
- other: not applicable, theoretical assessment
- Type:
- absorption
- Results:
- The substance can be absorbed by all three exposure routes; dermal absorption is expected to be limited.
- Type:
- distribution
- Results:
- 3-methoxy-N,N-dimethylpropamide is distributed to liver and kidneys.
- Type:
- metabolism
- Results:
- The amide bond may be susceptible to hydrolysis catalysed by amidases in the liver, gastrointestinal tract and blood.
- Type:
- excretion
- Results:
- Any metabolites are likely to be excreted in urine either in conjugated or non-conjugated form.
- Details on absorption:
- Systemic effects observed in the repeated dose toxicity studies and the reproduction/developmental toxicity screening test suggest that 3-methoxy-N,N-dimethylpropanamide is absorbed via oral route.
The molecular weight (131.12) of the substance is in the range to allow movement across the dermal membranes. The log Pow value for 3-methoxy-N,N-dimethylpropanamide was shown to be< 0.3 using the HPLC method and the estimated log Pow value was - 0.76 (Kowwin4), therefore dermal absorption is predicted to be limited based on the low log Pow value. The results from all studies with dermal exposure indicate that the substance has limited dermal absorptive potential. No adverse effects considered related to the test substance were observed in the acute dermal toxicity study and the substance was shown to be neither a skin irritant nor a skin sensitiser.
Clinical signs were observed in an acute inhalation study with 3-methoxy-N,N-dimethylpropanamide indicating that absorption may take place via this route, however, the substance has a low vapour pressure therefore a significant inhalation exposure to vapours is not expected. - Details on distribution in tissues:
- There are limited data available on the distribution of 3-methoxy-N,N-dimethylpropanamide in vivo. The substance was shown to be a non-sensitiser in a mouse local lymph node assay, which suggests that it does not bind significantly to proteins. The results of the repealed dose toxicity studies suggest that 3-methoxy-N,N-dimethylpropanamide and/or its metabolites are distributed to the liver and the kidney. Dimethylamine, which is likely to be formed as a result of hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide, is distributed widely throughout the body.
- Details on excretion:
- Acid-catalysed hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide is possible in the acidic conditions in the stomach (pH 1.5 to 3.5), however, the substance has been shown to be hydrolytically stable at pH 4. The amide bond in 3-methoxy-N,N-dimethylpropanamide may be susceptible to hydrolysis catalysed by amidases located in the liver, gastrointestinal tract and blood. Any products of hydrolysis are likely to be excreted in the urine either in conjugated or non-conjugated form. The major route of excretion for dimethylamine, which may be formed as a result of hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide, is in the urine; approximately 5% may be demethylated to methylamine. The plasma clearance of dimethylamine is estimated to be 190 mL/min and the elimination half-life is estimated to be 6 to 7 hours. Owing to its rapid metabolism and excretion, there appears to be little potential for accumulation of dimethylamine within tissues.
Bioaccumulation of 3-methoxy-N,N-dimethylpropanamide can most probably be excluded due to the fact that the substance is highly soluble in water, and has a low log Pow value(< 0.3). - Conclusions:
- A statement on toxicokinetic properties of 3-methoxy-N,N-dimethylpropanamide has been prepared based on its physico-chemical properties and the results from the available toxicity studies. Available data indicate that the substance can be absorbed through all three exposure routes. Based on the results of the repeated dose toxicity studies, the substance is distributed to the liver and kidneys. The amide bond in 3-methoxy-N,N-dimethylpropanamide may be susceptible to hydrolysis catalysed by amidases located in the liver, gastrointestinal tract and blood. Any products of hydrolysis are likely to be excreted in the urine either in conjugated or non-conjugated form. Bioaccumulation of 3-methoxy-N,N-dimethylpropanamide can most probably be excluded based on its high solubility in water and low log Pow.
- Executive summary:
A statement on toxicokinetic properties of 3-methoxy-N,N-dimethylpropanamide has been prepared based on its physico-chemical properties and the results from the available toxicity studies. Available data indicate that the substance can be absorbed through all three exposure routes. Adverse effects seen in the repeated dose toxicity and reproductive/developmental screening studies indicate potential for oral absorption.n The results from all studies with dermal exposure indicate that the substance has limited dermal absorptive potential. No adverse effects considered related to the test substance were observed in the acute dermal toxicity study and the substance was shown to be neither a skin irritant nor a skin sensitiser. Clinical signs were observed in an acute inhalation study with 3-methoxy-N,N-dimethylpropanamide indicating that absorption may take place via this route, however, the substance has a low vapour pressure therefore a significant inhalation exposure to vapours is not expected.
Based on the results of the repeated dose toxicity studies, the substance is distributed to the liver and kidneys. Acid-catalysed hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide is possible in the acidic conditions in the stomach (pH 1.5 to 3.5), however, the substance has been shown to be hydrolytically stable at pH 4. The amide bond in 3-methoxy-N,N-dimethylpropanamide may be susceptible to hydrolysis catalysed by amidases located in the liver, gastrointestinal tract and blood. Any products of hydrolysis are likely to be excreted in the urine either in conjugated or non-conjugated form. The major route of excretion for dimethylamine, which may be formed as a result of hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide, is in the urine; approximately 5% may be demethylated to methylamine. The plasma clearance of dimethylamine is estimated to be 190 mL/min and the elimination half-life is estimated to be 6 to 7 hours. Owing to its rapid metabolism and excretion, there appears to be little potential for accumulation of dimethylamine within tissues.
Bioaccumulation of 3-methoxy-N,N-dimethylpropanamide can most probably be excluded based on its high solubility in water and low log Pow.
Reference
Description of key information
Physico-chemical properties and the results from the available toxicity studies indicate that the substance can be absorbed through all three exposure routes. Based on the results of the repeated dose toxicity studies, the substance is distributed to the liver and kidneys. The amide bond in 3-methoxy-N,N-dimethylpropanamide may be susceptible to hydrolysis catalysed by amidases located in the liver, gastrointestinal tract and blood. Any products of hydrolysis are likely to be excreted in the urine either in conjugated or non-conjugated form. Bioaccumulation of 3-methoxy-N,N-dimethylpropanamide can most probably be excluded based on its high solubility in water and low log Pow.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
Available data indicate that the substance can be absorbed through all three exposure routes. Adverse effects seen in the repeated dose toxicity and reproductive/developmental screening studies indicate potential for oral absorption. In the absence of other data oral absorption is considered to be 100% as a worst-case. The results from all studies with dermal exposure suggest that the substance has limited dermal absorptive potential. No adverse effects considered related to the test substance were observed in the acute dermal toxicity study and the substance was shown to be neither a skin irritant nor a skin sensitiser. However, based on physico-chemical properties of the substance, 100% dermal absorption needs to be considered in accordance with Chapter R.7 of ECHA Guidance on information requirements and chemical safety assessment. Clinical signs were observed in an acute inhalation study with 3-methoxy-N,N-dimethylpropanamide indicating that absorption may take place via this route, however, the substance has a low vapour pressure therefore a significant inhalation exposure to vapours is not expected. However, for risk assessment purposes, as a worst-case 100% respiratory absorption will be considered.
Based on the results of the repeated dose toxicity studies, the substance is distributed to the liver and kidneys. Acid-catalysed hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide is possible in the acidic conditions in the stomach (pH 1.5 to 3.5), however, the substance has been shown to be hydrolytically stable at pH 4. The amide bond in 3-methoxy-N,N-dimethylpropanamide may be susceptible to hydrolysis catalysed by amidases located in the liver, gastrointestinal tract and blood. Any products of hydrolysis are likely to be excreted in the urine either in conjugated or non-conjugated form. The major route of excretion for dimethylamine, which may be formed as a result of hydrolysis of the amide bond in 3-methoxy-N,N-dimethylpropanamide, is in the urine; approximately 5% may be demethylated to methylamine. The plasma clearance of dimethylamine is estimated to be 190 mL/min and the elimination half-life is estimated to be 6 to 7 hours. Owing to its rapid metabolism and excretion, there appears to be little potential for accumulation of dimethylamine within tissues.
Bioaccumulation of 3-methoxy-N,N-dimethylpropanamide can most probably be excluded based on its high solubility in water and low log Pow.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.